online weight loss programs tirzepatide treatment Injections Chicago Semaglutide & Tirzepatide for Weight

Research Insights Superior Weight Loss Outcomes In a 48-week phase 2 study, adults with obesity treated with retatrutide experienced mean weight reductions of 22.8% (8 mg dose) and 24.2% (12 mg dose), outperforming other weight loss medications

Safety, Side Effects, and Clinical Expectations Common side effects of semaglutide include nausea, constipation, and mild headachetypically mild and self-limiting during the first 23 weeks of treatment

The bleed you get during your usual pill-free week isn't actually a true period at all

It is not known whether either of these routes is currently available for retatrutide

Planta Med 64(4):353356

B., Constantin-Teodosiu, D., et al